Loading…
Based on limited metadata, New Leaf Pharmaceuticals, LLC received an FDA Warning Letter on December 22, 2020, regarding drug products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The letter was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the specific compliance issues cited, review of the complete Warning Letter would be necessary.